# Biomat USA Inc – FDA Inspection, Sep 2, 2026

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/88274413-aad9-4710-b5c6-cf7ecbd43eaf
Source feed: FDA_Inspections

> FDA inspection 1335102 of Biomat USA Inc, September 02, 2026. 4 citations under 21 CFR parts 606 and 630. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1335102
- Company Name: Biomat USA Inc
- Inspection Date: 2026-09-02
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Denver District Office
- Citation Count: 4

## Related Documents

- FDA Inspection 1091480 - 2019-03-28

## Related Officers

- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)

Company: https://www.keypedia.com/companies/biomat-usa-inc/d6a2cd41-a03a-4a77-8797-ea321a2cf389

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face